Previous studies have reported that ghrelin has an inhibitory effect on sepsis-induced inflammation via the up-regulation of MKP-1 expression [41], and the administration of a GHSR-1a agonist to aging mice has been shown to restore a young liver phenotype; the latter occurs via an increase in PP2A activity [61]. Here, GHRL is linked to Sepsis.